Company Profile
Ensysce Biosciences Stock Price, News & Analysis
- Ticker:
- ENSC
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Ensysce Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
0.28 USD (+0.77%)
Close
Last updated: June 23, 2026 at 00:00
4.23M USD
Market cap
Why the stock is moving
ENSC is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Ensysce Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Ensysce Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Ensysce Biosciences follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Ensysce Biosciences sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
Ensysce Biosciences Reports First Quarter 2026 Financial Results
Source: Ensysce Biosciences
- 02
- 03
Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam
Source: Ensysce Biosciences
- 04
- 05
Ensysce Biosciences Expands Global Opioid Patent Portfolio
Source: Ensysce Biosciences
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Ensysce Biosciences (ENSC)?
Ensysce Biosciences (ENSC) most recently closed at 0.28 USD, a +0.77% move versus the previous session.
What is the market cap of Ensysce Biosciences (ENSC)?
Ensysce Biosciences currently has a market capitalization of 4.23M USD on BioPharmSignal.
What does Ensysce Biosciences do?
Ensysce Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is ENSC stock listed?
Ensysce Biosciences (ENSC) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Ensysce Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Ensysce?
Ensysce Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Ensysce Biosciences targeting with Ensysce?
Ensysce Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biosciences?
Ensysce Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.